Cargando…
One-Year Outcomes of Percutaneous Coronary Intervention in Patients with End-Stage Liver Disease
BACKGROUND: Patients with cirrhosis and coronary artery disease (CAD) are at high risk for morbidity during surgical revascularization so they are often referred for complex percutaneous coronary intervention (PCI). Percutaneous coronary intervention in the cirrhotic population also has inherent ris...
Autores principales: | Lu, Daniel Y, Saybolt, Matthew D, Kiss, Daniel H, Matthai, William H, Forde, Kimberly A, Giri, Jay, Wilensky, Robert L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6977100/ https://www.ncbi.nlm.nih.gov/pubmed/32030068 http://dx.doi.org/10.1177/1179546820901491 |
Ejemplares similares
-
From Coronaries to Cirrhosis: The Role of Percutaneous Coronary Intervention and Dual Antiplatelet Therapy in End-Stage Liver Disease
por: Remillard, Taylor C., et al.
Publicado: (2021) -
The Pros and Cons of Percutaneous Coronary Intervention in Patients With Cancer
por: Giri, Jay, et al.
Publicado: (2019) -
Safety and efficacy of dual antiplatelet therapy after percutaneous coronary interventions in patients with end-stage liver disease
por: Ostojic, Zvonimir, et al.
Publicado: (2021) -
Model for End-Stage Liver Disease Score Predicts the Mortality of Patients with Coronary Heart Disease Who Underwent Percutaneous Coronary Intervention
por: Chen, You, et al.
Publicado: (2021) -
Percutaneous coronary revascularization in patients with formerly "refractory angina pectoris in end-stage coronary artery disease" – Not "end-stage" after all
por: Jax, Thomas W, et al.
Publicado: (2009)